Skip to main content

Date: Aug. 22, 2023
Author: Andrew Amari, JD, APTA health policy and payment specialist

If you've been paying even just a little attention to APTA's regulatory advocacy efforts, you may have noticed a few new(ish) resources, seen calls to action using APTA's regulatory commenting tool, or heard pleas from the health policy and payment team to join us in commenting on a proposed rule.

If you're wondering what all the hubbub is about, or why APTA shifted its approach toward member-authored comment letters, it's because federal agencies have changed how they think about the comments they receive. It's in the profession's best interest to respond to those changes. As we ramp up our efforts to respond to the critically important 2024 Physician Fee Schedule proposed rule, here's an overview of why it's more important than ever to get involved in regulatory advocacy.

Log in or create a free account to keep reading.


Join APTA to get unlimited access to content.


You Might Also Like...

Article

Spending Deal Reached: Includes Some Relief From Fee Schedule Cuts

Mar 8, 2024

The package includes a 1.68% boost to the fee schedule but falls short of totally eliminating the cut to dozens of providers.

News

Senators From Both Parties Call for Action on Fee Schedule Cuts

Feb 28, 2024

Describing health care providers as "at a breaking point," 32 senators urge short- and long-term fixes as the next spending deadline looms.

News

APTA-Supported Bill Aims to Eliminate a Medicare Plan of Care Burden

Feb 8, 2024

Bipartisan legislation introduced in the House would relieve PTs from having to pursue signed plans of care from referring physicians.